News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,552 Results
Type
Article (3461)
Company Profile (5)
Press Release (26086)
Section
Business (8302)
Career Advice (34)
Deals (994)
Drug Delivery (5)
Drug Development (4746)
Employer Resources (3)
FDA (853)
Job Trends (843)
News (14692)
Policy (1200)
Tag
Academia (372)
Allergies (1)
Alliances (2032)
ALS (5)
Alzheimer's disease (81)
Antibody-drug conjugate (ADC) (7)
Approvals (856)
Artificial intelligence (11)
Autoimmune disease (1)
Bankruptcy (10)
Best Places to Work (758)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (4)
Bladder cancer (6)
Brain cancer (2)
Breast cancer (22)
Cancer (131)
Cardiovascular disease (12)
Career advice (33)
CAR-T (8)
Cell therapy (25)
Clinical research (3978)
Collaboration (37)
Compensation (6)
Complete response letters (1)
COVID-19 (125)
CRISPR (2)
C-suite (22)
Cystic fibrosis (11)
Data (175)
Depression (1)
Diabetes (13)
Diagnostics (226)
Diversity, equity & inclusion (2)
Drug discovery (6)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (7)
Earnings (2006)
Editorial (2)
Employer resources (3)
Events (4029)
Executive appointments (44)
FDA (906)
Frontotemporal dementia (1)
Funding (43)
Gene editing (6)
Gene therapy (11)
GLP-1 (31)
Government (147)
Guidances (2)
Healthcare (832)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (17)
Indications (2)
Infectious disease (130)
Inflammatory bowel disease (59)
Influenza (2)
Intellectual property (2)
Interviews (3)
IPO (438)
IRA (4)
Job creations (122)
Job search strategy (32)
Kidney cancer (2)
Labor market (1)
Layoffs (6)
Legal (187)
Liver cancer (3)
Lung cancer (15)
Lymphoma (12)
Manufacturing (14)
MASH (1)
Medical device (460)
Medtech (460)
Mergers & acquisitions (566)
Metabolic disorders (22)
Multiple sclerosis (10)
Neurodegenerative disease (8)
Neuropsychiatric disorders (1)
Neuroscience (111)
NextGen: Class of 2025 (301)
Non-profit (334)
Obesity (10)
Opinion (3)
Ovarian cancer (1)
Pain (3)
Pancreatic cancer (3)
Parkinson's disease (7)
Partnered (1)
Patents (5)
Patient recruitment (9)
Peanut (1)
People (3812)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase I (1100)
Phase II (1696)
Phase III (1555)
Pipeline (73)
Policy (8)
Postmarket research (172)
Preclinical (407)
Press Release (6)
Prostate cancer (6)
Radiopharmaceuticals (17)
Rare diseases (18)
Real estate (194)
Recruiting (1)
Regulatory (967)
Research institute (217)
Resumes & cover letters (2)
Schizophrenia (1)
Series A (10)
Series B (5)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (206)
Supply chain (2)
Tariffs (7)
The Weekly (1)
Vaccines (24)
Venture capitalists (1)
Weight loss (6)
Date
Today (7)
Last 7 days (34)
Last 30 days (119)
Last 365 days (1508)
2025 (485)
2024 (1595)
2023 (1973)
2022 (3206)
2021 (2573)
2020 (2277)
2019 (2206)
2018 (1647)
2017 (1626)
2016 (1613)
2015 (1753)
2014 (1302)
2013 (984)
2012 (981)
2011 (1047)
2010 (874)
Location
Africa (35)
Alaska (1)
Arizona (9)
Arkansas (1)
Asia (1148)
Australia (217)
California (345)
Canada (62)
China (24)
Colorado (13)
Connecticut (8)
Delaware (13)
Europe (4489)
Florida (29)
Georgia (21)
Idaho (3)
Illinois (27)
India (1)
Indiana (14)
Japan (9)
Kansas (5)
Louisiana (1)
Maine (1)
Maryland (16)
Massachusetts (162)
Michigan (12)
Minnesota (5)
Missouri (6)
Nebraska (2)
Nevada (3)
New Hampshire (1)
New Jersey (111)
New Mexico (1)
New York (90)
North Carolina (31)
North Dakota (1)
Northern California (150)
Ohio (21)
Oregon (1)
Pennsylvania (38)
South America (33)
Southern California (135)
Tennessee (2)
Texas (30)
United States (1017)
Utah (8)
Virginia (6)
Washington D.C. (1)
Washington State (20)
Wisconsin (2)
29,552 Results for "uc davis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc® trial at University of California, Davis (“UC Davis”) Medical Center in Sacramento, California.
January 26, 2024
·
7 min read
Press Releases
UC San Diego Celebrates the Naming of the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering
April 9, 2025
·
2 min read
Press Releases
Mabwell to Present Clinical Data of 9MW2821 Combined with Toripalimab in Patients with UC in an Oral Presentation at 2025 ASCO
April 24, 2025
·
5 min read
Press Releases
Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego
May 1, 2025
·
3 min read
Lone Star Bio
The Caris Precision Oncology Alliance Welcomes UC Davis Comprehensive Cancer Center
Caris Life Sciences®, the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition, announced that UC Davis Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™.
August 17, 2023
·
5 min read
Press Releases
Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
March 31, 2025
·
10 min read
Press Releases
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
February 20, 2025
·
4 min read
Press Releases
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn’s Disease and Ulcerative Colitis (UC)
November 21, 2024
·
6 min read
Press Releases
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
November 7, 2024
·
5 min read
Press Releases
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
October 23, 2024
·
6 min read
1 of 2,956
Next
